Sumatriptan succinate and Velcade drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Sumatriptan succinate (sumatriptan succinate) and Velcade (bortezomib). Common drug interactions include nausea among females and deep vein thrombosis among males.
The phase IV clinical study analyzes what interactions people have when they take Sumatriptan succinate and Velcade. It is created by eHealthMe based on reports of 12 people who take the same drugs from the FDA, and is updated regularly.
What is Sumatriptan succinate?
Sumatriptan succinate has active ingredients of sumatriptan succinate. It is often used in migraine. eHealthMe is studying from 9,731 Sumatriptan succinate users. Check the latest studies of Sumatriptan succinate.
What is Velcade?
Velcade has active ingredients of bortezomib. It is often used in multiple myeloma. eHealthMe is studying from 66,422 Velcade users. Check the latest studies of Velcade.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
12 people who take Sumatriptan succinate and Velcade together, and have interactions are studied.

What are the common drug interactions of Sumatriptan Succinate and Velcade, by gender? *:
female:
- Nausea (feeling of having an urge to vomit)
- Rash
- Abdominal pain
- Anorexia (eating disorder characterized by immoderate food restriction and irrational fear of gaining weight)
- Contusion (a type of hematoma of tissue in which capillaries)
- Erythema (redness of the skin)
- Headache (pain in head)
- Hypoaesthesia (reduced sense of touch or sensation)
- Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)
- Platelet count decreased
male:
- Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
- Fluid retention (an abnormal accumulation of fluid in the blood)
- Weight increased
- Depression
- Diarrhoea
- Erythema (redness of the skin)
- Eye swelling
- Laryngitis (inflammation of the larynx)
- Pruritus (severe itching of the skin)
- Rash
What are the common drug interactions of Sumatriptan Succinate and Velcade, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
- Blood calcium decreased
- Dehydration (dryness resulting from the removal of water)
- Haemoglobin decreased
- Nausea (feeling of having an urge to vomit)
- Vomiting
50-59:
- Abdominal pain
- Anorexia (eating disorder characterized by immoderate food restriction and irrational fear of gaining weight)
- Erythema (redness of the skin)
- Headache (pain in head)
- Hypoaesthesia (reduced sense of touch or sensation)
- Nausea (feeling of having an urge to vomit)
- Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)
- Platelet count decreased
- Proteinuria (presence of protein in the urine)
- Pyrexia (fever)
60+:
- Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
- Fluid retention (an abnormal accumulation of fluid in the blood)
- Confusional state
- Erythema (redness of the skin)
- Eye swelling
- Gaze palsy (disorders affecting the ability to move both eyes in the same direction)
- Laryngitis (inflammation of the larynx)
- Posterior reversible encephalopathy syndrome (posterior reversible encephalopathy syndrome (pres), also known as reversible posterior leukoencephalopathy syndrome (rpls), is a syndrome characterized by headache, confusion, seizures and visual loss)
- Thrombosis (formation of a blood clot inside a blood vessel)
- Weight increased
What are the existing conditions these people have? *
- Eye Swelling: 1 person, 8.33%
* Approximation only. Some reports may have incomplete information.
Do you take Sumatriptan succinate and Velcade?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Sumatriptan succinate (9,731 reports)
- Velcade (66,422 reports)
Browse all drug interactions of Sumatriptan succinate and Velcade:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Sumatriptan succinate:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Velcade:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Sumatriptan succinate and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Velcade and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on sumatriptan succinate and bortezomib (the active ingredients of Sumatriptan succinate and Velcade, respectively), and Sumatriptan succinate and Velcade (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Cymbalta cause Hearing Loss? - a second ago
- Bone Disorder and Pain In Extremity - 2 seconds ago
- Could Ibu cause Ischaemic Stroke? - 8 seconds ago
- Could Vicoprofen cause Haematuria? - 10 seconds ago
- Could Protonix cause Sexual Intercourse - Painful? - 11 seconds ago
- Could Plaquenil cause Adverse Event? - 13 seconds ago
- Hyperlipidaemia and Disturbance In Attention - 19 seconds ago
- Dilantin and Coumadin drug interactions for men aged 60+ - 23 seconds ago
- Could Ipratropium Bromide cause Muscle Disorder? - 25 seconds ago
- Could Warfarin Sodium cause Disability? - 27 seconds ago